These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17186740)

  • 41. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
    Martínez-Clemente M; Clària J; Titos E
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta cells in type 2 diabetes - a crucial contribution to pathogenesis.
    Maedler K
    Diabetes Obes Metab; 2008 May; 10(5):408-20. PubMed ID: 17451426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.
    Roden M
    Nat Clin Pract Endocrinol Metab; 2006 Jun; 2(6):335-48. PubMed ID: 16932311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteomic and bioinformatic analysis of membrane proteome in type 2 diabetic mouse liver.
    Kim GH; Park EC; Yun SH; Hong Y; Lee DG; Shin EY; Jung J; Kim YH; Lee KB; Jang IS; Lee ZW; Chung YH; Choi JS; Cheong C; Kim S; Kim SI
    Proteomics; 2013 Apr; 13(7):1164-79. PubMed ID: 23349036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative path to deep phenotyping: Possible importance of reduced hepatic insulin degradation to type 2 diabetes mellitus pathogenesis.
    Bergman RN; Piccinini F; Asare Bediako I; Kabir M; Kolka C; Polidori D; Ader M
    J Diabetes; 2018 Oct; 10(10):778-783. PubMed ID: 29961982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A case of esomeprazole-induced transient diabetes and hepatitis: the role of liver inflammation in the pathogenesis of insulin resistance.
    Zaccardi F; Pitocco D; Martini F; Caputo S; Miele L; Grieco A; Ghirlanda G
    Acta Diabetol; 2014 Feb; 51(1):151-3. PubMed ID: 22389003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Syndromes and pathological mechanism of insulin resistance in traditional Chinese medicine].
    Feng Q; Hu YY
    Zhong Xi Yi Jie He Xue Bao; 2005 Jan; 3(1):63-5. PubMed ID: 15644167
    [No Abstract]   [Full Text] [Related]  

  • 48. Type 2 diabetes and insulin resistance: an hepatocentric phenomenon?
    D'Alessio DA; Lê KA; Tappy L
    Curr Opin Clin Nutr Metab Care; 2005 Jul; 8(4):428-30. PubMed ID: 15930969
    [No Abstract]   [Full Text] [Related]  

  • 49. Advances in TCM research of insulin resistance.
    Shang W; Cheng H
    J Tradit Chin Med; 2001 Jun; 21(2):141-6. PubMed ID: 11498906
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pathogenesis of insulin resistance and prevention and treatment strategy of integrated traditional Chinese and western medicine].
    Wang SH; Wang WJ
    Zhong Xi Yi Jie He Xue Bao; 2004 Jan; 2(1):14-6. PubMed ID: 15339494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Relevance of cancer toxin pathogenesis theory with transformation of inflammation to carcinoma].
    Cheng HB; Shen WX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Feb; 35(2):243-6. PubMed ID: 25881473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxins and the Liver.
    Brown WM
    Buffalo Med J; 1910 Jun; 65(11):590-596. PubMed ID: 36884720
    [No Abstract]   [Full Text] [Related]  

  • 53. On the Theory of Inflammation.
    Hinton J
    Br Foreign Med Chir Rev; 1858 Jul; 22(43):209-222. PubMed ID: 30163902
    [No Abstract]   [Full Text] [Related]  

  • 54. [Discussion on thoughts and methods for treatment of diabetic nephropathy by TCM according to inflammatory pathogenesis].
    Piao CL; Nan HM; Jiang Z
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Apr; 25(4):365-7. PubMed ID: 15892288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of NF-κB decoy on insulin resistance of adipocytes from patients with type 2 diabetes mellitus.
    Zhong L; Luo Y; Huang C; Liu L
    Diabetes Metab; 2011 Dec; 37(6):520-6. PubMed ID: 21664164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Research progress on IR improvement and acting mechanisms of active ingredients of traditional Chinese medicine].
    Zheng H; Ge Y
    Zhongguo Zhong Yao Za Zhi; 2010 Feb; 35(4):531-5. PubMed ID: 20450060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications.
    Hung CH; Lee CM; Lu SN
    Expert Rev Anti Infect Ther; 2011 May; 9(5):525-33. PubMed ID: 21609264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Discussion on correlation between intrahepatic inflammatory pathogenesis and the TCM theory of liver collateral injury by toxins in patients of type 2 diabetes mellitus with insulin resistance].
    Yu M; Piao CL; Nan Z
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Nov; 26(11):1032-4. PubMed ID: 17186740
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.